Evidence map›Paper›PMID 42463829›Full record

ArticleBone marrow transplantation2026

Favorable outcomes after early allogeneic stem cell transplantation in adult early T-cell precursor acute lymphoblastic leukemia treated with the pediatric-inspired GIMEMA LAL1913 program. A Campus ALL study.

Gianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, Francesca Valsecchi, Anna Grassi, Marco Cerrano, Marzia Defina, Monia Lunghi, Fabio Giglio, Silvia Imbergamo and 15 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Gianluca CavallaroHematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Territoriale Ospedale Papa Giovanni XXIII, Bergamo, Italy. gcavallaro@asst-pg23.it.ORCID http://orcid.org/0009-0003-0507-8384
Davide LazzarottoClinica Ematologica-Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Chiara PavoniHematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Territoriale Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Francesca ValsecchiHematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Territoriale Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Anna GrassiHematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Territoriale Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Marco CerranoS.C. Ematologia, AOU Città della Salute e della Scienza-Presidio Molinette, Torino, Italy.
Marzia DefinaUOC Ematologia, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
Monia LunghiDivision of Hematology, Department of translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Fabio GiglioEmatologia e Trapianto di Midollo osseo, IRCCS Ospedale San Raffaele, Milano, Italy.ORCID http://orcid.org/0000-0003-4755-9533
Silvia ImbergamoEmatologia Azienda Ospedale Università di Padova, Padova, Italy.
Giuseppe LanzaroneDepartment of Oncology and Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
Antonino MulèU.O.C. di Oncoematologia AO Villa Sofia-Cervello, Palermo, Italy.
Prassede SalutariUOC Ematologia, Azienda USL di Pescara, Pescara, Italy.
Patrizia ZappasodiDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID http://orcid.org/0000-0001-9853-0592
Massimiliano BonifacioDepartment of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy.ORCID http://orcid.org/0000-0003-0716-1686
Patrizia ChiusoloDipartimento di Scienze Ematologiche e di laboratorio, Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia-Università Cattolica del Sacro Cuore, Roma, Italy.ORCID http://orcid.org/0000-0002-1355-1587
Mario DeliaEmatologia con Trapianto Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy.
Endri MauroUOC Ematologia, Ospedale Cà Foncello, Treviso, Italy.
Carla MazzoneHematology, Department of Medical Area, St. Eugenio Hospital, Rome, Italy.
Cristina SkertUOC Ematologia, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia, Italy.
Alessandro RambaldiFoundation of Clinical Research-FROM Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Sabina ChiarettiHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Robin FoàHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0002-5021-3026
Anna CandoniClinica Ematologica, Azienda Ospedaliero Universitaria di Modena e Dipartimento di Scienze Mediche e Chirurgiche, UNIMORE, Modena, Italy.ORCID http://orcid.org/0000-0003-4436-1310
Federico LussanaHematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Territoriale Ospedale Papa Giovanni XXIII, Bergamo, Italy.ORCID http://orcid.org/0000-0002-6510-8616

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) 21147Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) 21198
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42463829
PMCPMC13652723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.